Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2003
05/01/2003US20030082668 Method for measuring the activity of deacetylase and method of screening for inhibitors and accelerators of the enzyme
05/01/2003US20030082667 Novel alizarin-based chromogenic substrates, their uses and composition containing same
05/01/2003US20030082665 Fluorescent probe for use as diagnostic tool in monitoring preferential enzyme activity
05/01/2003US20030082663 Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone
05/01/2003US20030082662 Immunoassay and immunoassay apparatus
05/01/2003US20030082659 Group 2 allergen specific IgE-Fabs and use thereof
05/01/2003US20030082658 Method for fixing a biological molecule on a support surface
05/01/2003US20030082657 Oomycete FtsZ-mt as a target for oomycete-specific antimicrobials
05/01/2003US20030082655 Monoclonal antibody for use in the detection of ovarian cancer
05/01/2003US20030082654 Novel cancer marker and uses therefor in the diagnosis of cancer
05/01/2003US20030082652 Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer
05/01/2003US20030082651 Notch receptor agonists and uses
05/01/2003US20030082650 Great gene and protein
05/01/2003US20030082646 Antigenic targets of autoimmune sensorineural hearing loss (AISNHL) and development of tests for diagnosis and management of AISNHL
05/01/2003US20030082644 Detection of preferential nucleotide sequences in sample; provide biological sample, incubate with nucleic acid probes, detect hybridization signal, presence of signal indicates presence of target nucleotide sequences
05/01/2003US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89)
05/01/2003US20030082641 A method of treating depression using a galr3 receptor antagonist
05/01/2003US20030082640 Detecting modulation of low density lipoprotein receptor activity; provide binding polypeptide, incubate with test compound, screen and evaluate activity of modulator
05/01/2003US20030082639 Detecting herbicidal activity associated with test compound; obtain test sample, incubate with polypeptide, monitor and evaluate activty test compound
05/01/2003US20030082638 Methods for screening osteogenic compounds
05/01/2003US20030082634 Novel cell regulation factor TTO 20
05/01/2003US20030082633 Accelerating chemical reactions; obtain composite, incubate with reactant, apply electromagnet field to composite, recover product
05/01/2003US20030082632 Assay method and apparatus
05/01/2003US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity
05/01/2003US20030082630 Combinatorial libraries of monomer domains
05/01/2003US20030082629 Screening methods for compounds useful in the regulation of cell proliferation
05/01/2003US20030082628 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer and nervous system disorders
05/01/2003US20030082627 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082626 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082625 Pretreatment of a plastic surface; obtain surface, wash with a nonionic and cationic surfactant, evaluate plastic surface for presence non-specific binding of chemical intermediates
05/01/2003US20030082620 Novel human genes and gene expression products: II
05/01/2003US20030082619 Contiguous and partially overlapping cDNA sequences and polypeptides
05/01/2003US20030082617 Kit for use in determining net cholesterol mass flux of cholesterol containing cells
05/01/2003US20030082615 Olfactory receptor expression libraries and methods of making and using them
05/01/2003US20030082614 Map
05/01/2003US20030082612 Detection of mutant leptin receptor; obtain cells, extract nucleotide sequences, incubate with an oligonucleotide probe, detect hybridization, presence of hybridization, indicates defective receptor
05/01/2003US20030082609 Nuceotide sequences coding polypeptide for use in humans therapeutics and diagnostics
05/01/2003US20030082607 Nucleic acid hairpin probes and uses thereof
05/01/2003US20030082605 Genomic DNA detection method and system thereof
05/01/2003US20030082604 Preparation of microarray for use in the detection of preferential particles in sample; form solid support, incubate with nucleic acids conjugated to photoreactive group, illuminate applied spot, compare pattern to controls
05/01/2003US20030082603 Colon cancer marker
05/01/2003US20030082601 Enzyme-amplified redox microarray detection process
05/01/2003US20030082600 Highly sensitive method for the detection of cytosine methylation patters
05/01/2003US20030082597 Age-associated markers
05/01/2003US20030082594 Detection of preferential parasite in sample; obtain sample, extract nucleotide sequence, incubate with probe, detect signal, presence of signal indicate parasite
05/01/2003US20030082593 Diagnosing cancer in humans; obtain lymphocytes, monitor preferential cd antigen expression, compare to control, evaluate for cancer
05/01/2003US20030082591 Methods for gene disruption and uses thereof
05/01/2003US20030082590 Exponential nucleic acid amplification using nicking endonucleases
05/01/2003US20030082589 Assay
05/01/2003US20030082588 Method for immobilizing molecules onto surfaces
05/01/2003US20030082587 Microarrays for use in the detection and analysis of biopolymers
05/01/2003US20030082579 Generating library of preferential polypeptides; obtain nucleotide sequences, incubate with primers, amplify, recover amplification product, transform and express sequence incell, monitor and evaluate cell activity
05/01/2003US20030082572 Methods and compositions for nucleotide analysis
05/01/2003US20030082571 Linear nucleic acid and sequence therefor
05/01/2003US20030082569 Histoplasma capsulatum catalase sequences and their use in the detection of Histoplasma capsulatum and Histoplasmosis
05/01/2003US20030082564 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders
05/01/2003US20030082560 Method of making interactive protein arrays
05/01/2003US20030082558 Preparation of labelled nucleotide sequences; obtain nucleotide sequences, denature, incubate with primer, polymerase and and labelled amplification mixture, amplify, recover labelled nucleotide sequences
05/01/2003US20030082556 Binary encoded sequence tags
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082548 Brain selective transmembrane receptor gene
05/01/2003US20030082547 Non-fluorescent quencher compounds and biomolecular assays
05/01/2003US20030082542 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082541 Nucleotide sequences coding polypeptide for use in the treatment of skin disorders and cancer
05/01/2003US20030082540 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082539 Detecting biological warfare agent; obtain nucleotide sequences, incubate with primers, amplify, determine mass of amplification product, compare to control, classify amplification product
05/01/2003US20030082538 Analysis of data from liquid chromatographic separation of DNA
05/01/2003US20030082526 Diagnosis and treatment of cancer
05/01/2003US20030082523 Diagnosing viral infection in mammals; obtain fluid sample, extract nucleotide sequences, incubate with viral probe, detect hybridization, hybridization signal indicates presence of viral sequence
05/01/2003US20030082522 Compound for use as diagnostic tool in protein analysis
05/01/2003US20030082520 Procedure for quantitative determination of viral particles having a cholesterol-containing envelope
05/01/2003US20030082519 Cellular kinases involved in Cytomegalovirus infection and their inhibition
05/01/2003US20030082518 Genetic engineering; quantitative analysis; medical diagnosis
05/01/2003US20030082517 Treating viral disease in mammals; administer viricide to mammal, monitor activity of virus, reduced viral activity indicates effective viricide
05/01/2003US20030082516 Rapid detection of replicating cells
05/01/2003US20030082515 Detecting modulator of cell proliferation, differentiation, viability, phenotypes or activity; prepare culture, incubate with modulator, monitor adjustment in cell characteristics, adjustment in characteristics indicate modulator
05/01/2003US20030082514 Detecting active biopolymers in sample; provide vectors, transduce cells, recover transduced cells, propagate cells, detect adjusted phenotypes, sequence nucleotide acids in trangenic cells, isolated ligand for biopolymers
05/01/2003US20030082513 Detecting cell to cell activity in sample; obtain cells, polarize, incubate with fluorescent dye, determine membrane potential of cells, monitor adjustment in membrane potenial between cells
05/01/2003US20030082511 Identification of modulatory molecules using inducible promoters
05/01/2003US20030082444 Molehole embedded 3-D crossbar architecture used in electrochemical molecular memory device
05/01/2003US20030082417 Calibration process and apparatus for an electrochemical cell system
05/01/2003US20030082294 Surface treatment method for bio-arrays
05/01/2003US20030082238 Matrices for drug delivery and methods for making and using the same
05/01/2003US20030082208 Protein having multiple antigen/epitope sequences and being immobilized
05/01/2003US20030082188 Treatment of prostate cancer by inhibitors of NCAM2
05/01/2003US20030082182 Antiinflammatory agents, inflammatory bowel disorders, antiulcer agents
05/01/2003US20030082179 Complexing antibody with poarathyroid hormone
05/01/2003US20030082173 Screening drugs that block lymphocytes; genetic engineered rodent
05/01/2003US20030082172 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
05/01/2003US20030082171 Deafness therapy, prevention; mylein protein vaccine
05/01/2003US20030082155 Antidiabetic agents; cell differentiation of stem cells
05/01/2003US20030082153 Stem cells that transform to beating cardiomyocytes
05/01/2003US20030082135 Pathway of RANTES-mediated chemokine synthesis in astrocytes and methods of use therefor
05/01/2003US20030082077 Shaped metallic foils are converted into free-standing, porous rutile foils having open pore structure by oxidation at elevated temperature; exposure to increasing concentrations of reducing gas (carbon monoxide) increases electrical resistance
05/01/2003US20030082076 Disposable electrode for whole blood hemoglobin (HGB) and hematocrit (HCT) measurement, and preparation and application
05/01/2003US20030082074 Visual blood glucose test strip
05/01/2003US20030081209 Apparatus and method for measuring micro area in specimen
05/01/2003US20030080758 Method of evaluating the time left before gelation of a thermosetting composition
05/01/2003US20030080753 Multiple frequency grain moisture sensor for combines
05/01/2003US20030080735 Sensor for detecting defects in a component